Girgenti MJ, Nisenbaum LK, Bymaster F, Terwilliger R, Duman RS, Newton SS. Antipsychotic-induced gene regulation in multiple brain regions. J Neurochem. 2010;113:175–87.
Article
CAS
PubMed
PubMed Central
Google Scholar
MacDonald ML, Eaton ME, Dudman JT, Konradi C. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry. 2005;57:1041–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lencz T, Malhotra AK. Pharmacogenetics of antipsychotic-induced side effects. Dialogues Clin Neurosci. 2009;11:405–15.
PubMed
PubMed Central
Google Scholar
Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. Can Med Assoc J. 2005;172:1703–11.
Article
Google Scholar
Akbarian S. Epigenetic mechanisms in schizophrenia. Dialogues Clin Neurosci. 2014;16:405–17.
PubMed
PubMed Central
Google Scholar
Dempster E, Viana J, Pidsley R, Mill J. Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future. Schizophr Bull. 2013;39:11–6.
Article
PubMed
Google Scholar
O'Brien E, Dedova I, Duffy L, Cordwell S, Karl T, Matsumoto I. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res. 2006;1113:24–32.
Article
PubMed
Google Scholar
Ji B, La Y, Gao L, Zhu H, Tian N, Zhang M, Yang Y, Zhao X, Tang R, Ma G, et al. A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications. J Proteome Res. 2009;8:3633–41.
Article
CAS
PubMed
Google Scholar
Kedracka-Krok S, Swiderska B, Jankowska U, Skupien-Rabian B, Solich J, Buczak K, Dziedzicka-Wasylewska M. Clozapine influences cytoskeleton structure and calcium homeostasis in rat cerebral cortex and has a different proteomic profile than risperidone. J Neurochem. 2015;132:657–76.
Article
CAS
PubMed
Google Scholar
Davalieva K, Maleva Kostovska I, Dwork AJ. Proteomics research in schizophrenia. Front Cell Neurosci. 2016;10:18.
Article
PubMed
PubMed Central
Google Scholar
Baloyianni N, Tsangaris GT. The audacity of proteomics: a chance to overcome current challenges in schizophrenia research. Exp rev proteomics. 2009;6:661–74.
Article
Google Scholar
Savino R, Paduano S, Preiano M, Terracciano R. The proteomics big challenge for biomarkers and new drug-targets discovery. Int J Mol Sci. 2012;13:13926–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154–69.
Article
CAS
PubMed
Google Scholar
Craft GE, Chen A, Nairn AC. Recent advances in quantitative neuroproteomics. Methods. 2013;61:186–218.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yin HR, Zhang L, Xie LQ, Huang LY, Xu Y, Cai SJ, Yang PY, Lu HJ. Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker. J Proteome Res. 2013;12:3912–9.
Article
CAS
PubMed
Google Scholar
Pottiez G, Wiederin J, Fox HS, Ciborowski P. Comparison of 4-plex to 8-plex iTRAQ quantitative measurements of proteins in human plasma samples. J Proteome Res. 2012;11:3774–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saia-Cereda VM, Cassoli JS, Schmitt A, Falkai P, Martins-de-Souza D. Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients. Schizophr Res. 2016;177:70–7.
Article
PubMed
Google Scholar
Corena-McLeod M, Walss-Bass C, Oliveros A, Gordillo Villegas A, Ceballos C, Charlesworth CM, Madden B, Linser PJ, Van Ekeris L, Smith K, Richelson E. New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations. PLoS One. 2013;8:e52147.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharma RP, Grayson DR, Gavin DP. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res. 2008;98:111–7.
Article
PubMed
Google Scholar
Benes FM, Lim B, Matzilevich D, Subburaju S, Walsh JP. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci U S A. 2008;105:20935–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 2002;30:2930–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem. 2005;93:483–92.
Article
CAS
PubMed
Google Scholar
Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH. Recovery of learning and memory is associated with chromatin remodelling. Nature. 2007;447:178–82.
Article
CAS
PubMed
Google Scholar
Kim HJ, Leeds P, Chuang DM. The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem. 2009;110:1226–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009;459:55–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH, Moy LY, Giusti P, et al. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron. 2008;60:803–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase a and NMDA receptor signaling. J Neurochem. 2004;90:1117–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonito-Oliva A, Sodersten E, Spigolon G, Hu X, Hellysaz A, Falconi A, Gomes AL, Broberger C, Hansen K, Fisone G. Differential regulation of the phosphorylation of Trimethyl-lysine27 histone H3 at serine 28 in distinct populations of striatal projection neurons. Neuropharmacology. 2016;107:89–99.
Article
CAS
PubMed
Google Scholar
Bozidis P, Hyphantis T, Mantas C, Sotiropoulou M, Antypa N, Andreoulakis E, Serretti A, Mavreas V, Antoniou K. HSP70 polymorphisms in first psychotic episode drug-naive schizophrenic patients. Life Sci. 2014;100:133–7.
Article
CAS
PubMed
Google Scholar
Focking M, Lopez LM, English JA, Dicker P, Wolff A, Brindley E, Wynne K, Cagney G, Cotter DR. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry. 2015;20:424–32.
Article
CAS
PubMed
Google Scholar
Cacabelos R, Torrellas C. Epigenetics of aging and Alzheimer's disease: implications for pharmacogenomics and drug response. Int J Mol Sci. 2015;16:30483–543.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pennington K, Dicker P, Dunn MJ, Cotter DR. Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics. 2008;8:5097–107.
Article
CAS
PubMed
Google Scholar
Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 2004;77:858–66.
Article
CAS
PubMed
Google Scholar
Cassoli JS, Iwata K, Steiner J, Guest PC, Turck CW, Nascimento JM, Martins-de-Souza D. Effect of MK-801 and clozapine on the proteome of cultured human oligodendrocytes. Front Cell Neurosci. 2016;10:52.
Article
PubMed
PubMed Central
Google Scholar
Chen ML. Two-dimensional gel electrophoresis revealed antipsychotic drugs induced protein expression modulations in C6 glioma cells. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;40:1–11.
Article
Google Scholar
Scott DD, Oeffinger M. Nucleolin and nucleophosmin: nucleolar proteins with multiple functions in DNA repair. Biochem Cell Biol. 2016;94:419–32.
Article
CAS
PubMed
Google Scholar
Inder KL, Lau C, Loo D, Chaudhary N, Goodall A, Martin S, Jones A, van der Hoeven D, Parton RG, Hill MM, Hancock JF. Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction. J Biol Chem. 2009;284:28410–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Funk AJ, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacology. 2012;37:896–905.
Article
CAS
PubMed
Google Scholar
Kyosseva SV, Elbein AD, Griffin WS, Mrak RE, Lyon M, Karson CN. Mitogen-activated protein kinases in schizophrenia. Biol Psychiatry. 1999;46:689–96.
Article
CAS
PubMed
Google Scholar
Katsel P, Byne W, Roussos P, Tan W, Siever L, Haroutunian V. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology. 2011;36:1171–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feresten AH, Barakauskas V, Ypsilanti A, Barr AM, Beasley CL. Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness. Schizophr Res. 2013;150:252–7.
Article
PubMed
Google Scholar
Svitkina TM, Verkhovsky AB, Borisy GG. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J Cell Biol. 1996;135:991–1007.
Article
CAS
PubMed
Google Scholar
Wiche G, Osmanagic-Myers S, Castanon MJ. Networking and anchoring through plectin: a key to IF functionality and mechanotransduction. Curr Opin Cell Biol. 2015;32:21–9.
Article
CAS
PubMed
Google Scholar
Eriksson M, Samuelsson H, Samuelsson EB, Liu L, McKeehan WL, Benedikz E, Sundstrom E. The NMDAR subunit NR3A interacts with microtubule-associated protein 1S in the brain. Biochem Biophys Res Commun. 2007;361:127–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eriksson M, Nilsson A, Samuelsson H, Samuelsson EB, Mo L, Akesson E, Benedikz E, Sundstrom E. On the role of NR3A in human NMDA receptors. Physiol Behav. 2007;92:54–9.
Article
CAS
PubMed
Google Scholar
Mueller HT, Meador-Woodruff JH. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res. 2004;71:361–70.
Article
PubMed
Google Scholar
Henson MA, Roberts AC, Salimi K, Vadlamudi S, Hamer RM, Gilmore JH, Jarskog LF, Philpot BD. Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb Cortex. 2008;18:2560–73.
Article
PubMed
PubMed Central
Google Scholar